News
Successful closing of Araris Biotech Ltd CHF 2.5 million seed financing round
26. August 2019
Only six months after its incorporation, Araris Biotech Ltd has closed an oversubscribed seed financing round of CHF 2.5 million from Swiss venture capitalists Redalpine, Schroder Adveq and VI Partners.
Araris Biotech Ltd is a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich pioneering a novel antibody-drug conjugate (ADC)-linker technology. Araris’ linker platform enables the attachment of any payload to “off the shelf” antibodies without the need of prior antibody engineering.
Araris Biotech Ltd was advised in all legal matters with regard to the seed financing round by Bader Gnehm & Partner. The team consisted of Oliver Gnehm (Partner) and Denis A. Parvex (Associate).
Memo Therapeutics Ltd closes Series A2-Second Tranche
24. July 2019
Memo Therapeutics Ltd, is a biotech spin-off company from ETH Zurich and innovator in the field of antibody discovery and immune repertoire analysis.
Memo Therapeutics Ltd was advised in all legal matters with regard to the Series A2-Financing Round (Second Tranche) by Bader Gnehm & Partner. The team was led by Oliver Gnehm (Partner) and furthermore included Denis A. Parvex (Associate).
20. Jazz Brunch
09. July 2019
Our 20. Jazz-Brunch took place on Sunday, June 23th, 2019 on the Gurten Hill Bern
BGP advises Lalique regarding the acquisition of 50% of The Glenturret
10. May 2019
The acquisition of The Glenturret, Scotland’s oldest still active single malt whisky distillery, was carried out though a joint venture in which Lalique Group SA and Swiss entrepreneur Hansjoerg Wyss each hold 50%.
Lalique Group SA is a niche player in the creation, development, marketing and global distribution of luxury goods. Its business areas comprise perfumes, cosmetics, crystal, jewelry, high-end furniture and home accessories, along with art, gastronomy and hospitality. The shares of Lalique Group SA are listed on the SIX Swiss Exchange (LLQ).
Lalique Group SA was advised in all legal matters with regard to the Joint Venture by Bader Gnehm & Partner. The team was led by Oliver Gnehm (Partner) and furthermore included Denis A. Parvex (Associate).
The press release of Lalique Group SA can be found below.
BGP was awarded
26. April 2019
BGP is proud to be among the "Top Law Firms 2019" in Switzerland. This award is based on the list of Switzerland's top law firms published by the Swiss business magazine BILANZ and newspaper LE TEMPS.
BGP was awarded 5 out of 5 stars in the "Private Equity and Venture Capital" category.
We would like to thank our clients and business partners for their trust and support. Only thanks to them have we received this award.